Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7495)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2019 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He C, Wang H, Liao WD, Peng C, Shu X, Zhu X, Zhu ZH. Characteristics of mucosa-associated gut microbiota during treatment in Crohn’s disease. World J Gastroenterol 2019; 25(18): 2204-2216 [PMID: 31143071 DOI: 10.3748/wjg.v25.i18.2204] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v25/i18/2204.htm |
| Number | Citing Articles |
| 1 |
Hua Zha, Haifeng Lu, Jieyun Wu, Kevin Chang, Qiangqiang Wang, Hua Zhang, Jinyou Li, Qixia Luo, Yanmeng Lu, Lanjuan Li. Vital Members in the More Dysbiotic Oropharyngeal Microbiotas in H7N9-Infected Patients. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00396
|
| 2 |
Pan Cao, Qian Chen, Chunxia Shi, Maohua Pei, Luwen Wang, Zuojiong Gong. Fusobacterium Nucleatum Promotes the Development of Acute Liver Failure by Inhibiting the NAD <sup>+</sup> Salvage Metabolic Pathway. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3930219
|
| 3 |
Shiva T. Radhakrishnan, James L. Alexander, Benjamin H. Mullish, Kate I. Gallagher, Nick Powell, Lucy C. Hicks, Ailsa L. Hart, Jia V. Li, Julian R. Marchesi, Horace R. T. Williams. Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2022; 55(1): 26 doi: 10.1111/apt.16656
|
| 4 |
Kinga Kowalska-Duplaga, Przemysław Kapusta, Tomasz Gosiewski, Agnieszka Sroka-Oleksiak, Agnieszka H. Ludwig-Słomczyńska, Paweł P. Wołkow, Krzysztof Fyderek. Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease. Journal of Clinical Medicine 2020; 9(3): 687 doi: 10.3390/jcm9030687
|
| 5 |
Haichao Wang, Guorong Yan, Yaling Wu, Deji Zhuoma, Zhanju Liu, Xuefeng Gao, Xiaolei Wang. Fecal microbiota related to postoperative endoscopic recurrence in patients with Crohn's disease. Gastroenterology Report 2023; 12 doi: 10.1093/gastro/goae017
|
| 6 |
Carolina Serena, Maribel Queipo-Ortuño, Monica Millan, Lidia Sanchez-Alcoholado, Aleidis Caro, Beatriz Espina, Margarita Menacho, Michelle Bautista, Diandra Monfort-Ferré, Margarida Terrón-Puig, Catalina Núñez-Roa, Elsa Maymó-Masip, M. Mar Rodriguez, Francisco J. Tinahones, Eloy Espin, Marc Martí, Sonia Fernández-Veledo, Joan Vendrell. Microbial Signature in Adipose Tissue of Crohn’s Disease Patients. Journal of Clinical Medicine 2020; 9(8): 2448 doi: 10.3390/jcm9082448
|
| 7 |
Hua Zha, Jiafeng Xia, Guinian Si, Ruiqi Tang, Shengjie Li, Qian Li, Yiqing Lou, Wanlong Wo, Kevin Chang, Lanjuan Li. Characteristics of the intestinal bacterial microbiota profiles in Bifidobacterium pseudocatenulatum LI09 pre-treated rats with D-galactosamine-induced liver injury. World Journal of Microbiology and Biotechnology 2023; 39(2) doi: 10.1007/s11274-022-03495-y
|
| 8 |
Motoyasu Osawa, Osamu Handa, Shinya Fukushima, Hiroshi Matsumoto, Eiji Umegaki, Ryo Inoue, Yuji Naito, Akiko Shiotani. Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients. Journal of Clinical Biochemistry and Nutrition 2023; 73(1): 77 doi: 10.3164/jcbn.22-86
|
| 9 |
Hua Zha, Fengping Liu, Zongxin Ling, Kevin Chang, Jiezuan Yang, Lanjuan Li. Multiple bacteria associated with the more dysbiotic genitourinary microbiomes in patients with type 2 diabetes mellitus. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81507-x
|
| 10 |
Pan Cao, Yongyu Chen, Xufeng Guo, Yan Chen, Wenhao Su, Na Zhan, Weiguo Dong. Fusobacterium nucleatum Activates Endoplasmic Reticulum Stress to Promote Crohn’s Disease Development via the Upregulation of CARD3 Expression. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00106
|
| 11 |
Jemmie Hoang, Stephanie Gilbertson-White, Nicole Cady, Meeta Yadav, Shailesh Shahi, Leeann Aguilar, Ashutosh K. Mangalam, Catherine Cherwin. Preliminary Analysis of Gut Microbiome and Gastrointestinal Symptom Burden in Breast Cancer Patients Receiving Chemotherapy Compared to Healthy Controls. Biological Research For Nursing 2024; 26(2): 219 doi: 10.1177/10998004231205277
|
| 12 |
Jin-kun Wang, Bo Yan, Jun-mei Zhao, Li-ping Yuan. Effect of gut microbiota from Henoch-Schönlein Purpura patients on acid-sensitive ion channel 3 expression and intestinal motility in germ-free rats. BMC Pediatrics 2021; 21(1) doi: 10.1186/s12887-021-03013-3
|
| 13 |
Francesco Di Pierro. Gut Microbiota Parameters Potentially Useful in Clinical Perspective. Microorganisms 2021; 9(11): 2402 doi: 10.3390/microorganisms9112402
|
| 14 |
Osamu Handa, Hiroto Miura, Tingting Gu, Motoyasu Osawa, Hiroshi Matsumoto, Eiji Umegaki, Ryo Inoue, Yuji Naito, Akiko Shiotani. Reduction of butyric acid-producing bacteria in the ileal mucosa-associated microbiota is associated with the history of abdominal surgery in patients with Crohn’s disease. Redox Report 2023; 28(1) doi: 10.1080/13510002.2023.2241615
|
| 15 |
Jagadesan Sankarasubramanian, Rizwan Ahmad, Nagavardhini Avuthu, Amar B. Singh, Chittibabu Guda. Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.606298
|
| 16 |
Samuel Adefisoye Lawal, Athalia Voisin, Hana Olof, Michael Bording-Jorgensen, Heather Armstrong. Diversity of the microbiota communities found in the various regions of the intestinal tract in healthy individuals and inflammatory bowel diseases. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1242242
|
| 17 |
Katarzyna Karpinska-Leydier, Jashvini Amirthalingam , Khadija Alshowaikh, Anuruddhika Iroshani Jayarathna, Divya Bala Anthony Manisha R Salibindla, Gokul Paidi, Huseyin Ekin Ergin. Correlation Between the Gut Microbiome and Immunotherapy Response in Inflammatory Bowel Disease: A Systematic Review of the Literature. Cureus 2021; doi: 10.7759/cureus.16808
|
| 18 |
M. V. Osikov, N. V. Kaygorodtceva, M. S. Boyko, L. V. Astachova. Clinical and Morphological Analysis of Efficacy of Intraperitoneal Ozone Application in Experimental Colitis: Preclinical Randomized Experimental Study. Kuban Scientific Medical Bulletin 2023; 30(1): 98 doi: 10.25207/1608-6228-2023-30-1-98-108
|
| 19 |
Ahmed Elolimy, Abdulrahman Alharthi, Mohamed Zeineldin, Claudia Parys, Ariane Helmbrecht, Juan J. Loor. Supply of Methionine During Late-Pregnancy Alters Fecal Microbiota and Metabolome in Neonatal Dairy Calves Without Changes in Daily Feed Intake. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.02159
|
| 20 |
Cong He, Huan Wang, Chen Yu, Chao Peng, Xu Shu, Wangdi Liao, Zhenhua Zhu. Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn’s Disease. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.673691
|
| 21 |
Pan Cao, Qian Chen, Chunxia Shi, Luwen Wang, Zuojiong Gong. Fusobacterium nucleatum promotes the development of acute liver failure by inhibiting the NAD+ salvage metabolic pathway. Gut Pathogens 2022; 14(1) doi: 10.1186/s13099-022-00503-2
|
| 22 |
Hua Zha, Dai-Qiong Fang, Aimee van der Reis, Kevin Chang, Li-Ya Yang, Jiao-Jiao Xie, Ding Shi, Qiao-Mai Xu, Ya-Ting Li, Lan-Juan Li. Vital members in the gut microbiotas altered by two probiotic Bifidobacterium strains against liver damage in rats. BMC Microbiology 2020; 20(1) doi: 10.1186/s12866-020-01827-2
|
| 23 |
Marilina Florio, Lucilla Crudele, Antonio Moschetta, Raffaella M. Gadaleta. Gut Microbiome, Microbial Metabolites and Cardiometabolic Risk. Endocrinology 2024; : 333 doi: 10.1007/978-3-031-35064-1_14
|
| 24 |
Shinya Fukushima, Akiko Shiotani, Hiroshi Matsumoto, Osamu Handa, Yukiko Handa, Motoyasu Osawa, Takahisa Murao, Eiji Umegaki, Mitsuoki Kawano, Ryo Inoue, Yuji Naito. Comparison of mucosa-associated microbiota in Crohn’s disease patients with and without anti-tumor necrosis factor-α therapy. Journal of Clinical Biochemistry and Nutrition 2022; 70(2): 182 doi: 10.3164/jcbn.21-41
|
| 25 |
Hua Zha, Yanfei Chen, Jieyun Wu, Kevin Chang, Yanmeng Lu, Hua Zhang, Jiaojiao Xie, Qiangqiang Wang, Ruiqi Tang, Lanjuan Li. Characteristics of three microbial colonization states in the duodenum of the cirrhotic patients. Future Microbiology 2020; 15(10): 855 doi: 10.2217/fmb-2019-0270
|
| 26 |
Xiao shan Wang, Pei xuan Li, Bao shan Wang, Wang dong Zhang, Wen hui Wang. Integrated omics analysis reveals the immunologic characteristics of cystic Peyer’s patches in the cecum of Bactrian camels. PeerJ 2023; 11: e14647 doi: 10.7717/peerj.14647
|
| 27 |
Yuzhu Peng, Qi Zhao, Shuijiao Chen, Zhenyu Li, Di An, Xian Zhang. Potential contributions of keystone species to intestinal ecosystem in patients with Crohn's disease. Journal of Applied Microbiology 2024; 135(4) doi: 10.1093/jambio/lxae086
|
| 28 |
Marilina Florio, Lucilla Crudele, Antonio Moschetta, Raffaella M. Gadaleta. Gut Microbiome, Microbial Metabolites and Cardiometabolic Risk. Endocrinology 2023; : 1 doi: 10.1007/978-3-031-08115-6_14-1
|